Joseph M.
Rogers
ab,
Mickal
Nawatha
c,
Betsegaw
Lemma
d,
Ganga B.
Vamisetti
c,
Ido
Livneh
e,
Uri
Barash
e,
Israel
Vlodavsky
e,
Aaron
Ciechanover
e,
David
Fushman
d,
Hiroaki
Suga
*a and
Ashraf
Brik
*c
aDepartment of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. E-mail: hsuga@chem.s.u-tokyo.ac.jp
bDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark
cSchulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa 3200008, Israel. E-mail: abrik@technion.ac.il
dDepartment of Chemistry and Biochemistry, Center for Biomolecular Structure and Organization, University of Maryland, College Park, MD 20742, USA
eThe Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel
First published on 11th May 2021
Correction for ‘In vivo modulation of ubiquitin chains by N-methylated non-proteinogenic cyclic peptides’ by Joseph M. Rogers et al., RSC Chem. Biol., 2021, 2, 513–522, DOI: 10.1039/D0CB00179A.
This study was also funded by the National Institutes of Health under grant GM065334 to D.F. and A.B.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2021 |